Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT04141020
PHASE2
Effect of Sirolimus on Molecular Alterations in Cerebral Aneurysms
Sponsor: University of Miami
View on ClinicalTrials.gov
Summary
The objective of this study is to explore the effects of Sirolimus on the underlying molecular alterations of cerebral aneurysms.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2021-10-27
Completion Date
2026-11-01
Last Updated
2026-03-23
Healthy Volunteers
No
Conditions
Interventions
PROCEDURE
Microsurgical clipping
Standard of care microsurgical clipping of an unruptured cerebral artery aneurysm.
PROCEDURE
Endovascular treatment
Standard of care endovascular treatment of an unruptured cerebral artery aneurysm.
DRUG
Sirolimus
Daily oral Sirolimus 2 mg tablets, adjusted as necessary per treating physician.
Locations (1)
University of Miami
Miami, Florida, United States